BATON ROUGE – Critics across the country wonder why Dsuvia is needed. It is a new opioid and analgesic who has recently received a seal of approval from the FDA, but many disagree and think it's a terrible mistake.
"We are probably the worst epidemic in the world, which is an opioid epidemic in this country that is likely to kill and hurt more people than any other epidemic from the earth or the world," said coroner Beau Clark.
Eastern Baton Rouge Parish Coroner Dr Beau Clark first saw the fatal effects of opioid use with at least 72 victims of overdose in the parish this year alone.
"This looks like a real open neglect of human life, we talk about substances, opioids killing people, why we need it more when we have problems with what we have," Clark said.
According to the FDA, there are strict guidelines for the drug that dissolves in your mouth. It can only be used in hospitals, surgical centers and emergency departments. Dsuvia should not be used for more than 72 hours and is not available in retail pharmacies.
They say this is a drug that will only be used in a health center for a very short time in a highly controlled environment. That's great if that's the case. However, later in the statement, they say it has also been developed with the Ministry of Defense, so it also contradicts itself.
In a statement from the FDA commission, Dr. Sc. Scott Gottlieb says, "This opioid formulation, along with a unique delivery device for Dsuvia, was the media priority product of the Pentagon because it fulfills a specific and vital, but limited, unsatisfied need for treating our nation's soldiers, but Dr. Clark does not buy it.
"A soldier is out there that protects our country, and if he gets hurt on the battlefield, we must have mechanisms to manage his pain, especially if we have a long transport time from where they are hurt and definitely taken care of, but I think those things already exist," Clark said.
Serious risks of using Dsuvia include respiratory depression, knee and even death and not to mention highly contagious quality.
"The existence of stronger and stronger opiates is in fact the wrong direction and certainly sends the wrong message." In Dr. Gottlieb's statement on Dwight, he added: "We will not avoid what I believe is the real root cause of dissatisfaction among the critics of this approval, whether America needs another powerful opioid, while in the grip of a massive crisis of addiction."
Gottlieb says this issue will be resolved openly and directly. Dsuvia will bring $ 1.1 billion a year of sales, but Clark is more concerned about the lives that could be lost in the future.
"We are on the road for another record year of increasing the number of opioids compared to last year, and I do not see the end in sight, and when we do something similar and create another category of even more powerful Opioid I think it leads more and more problems," he said is Clark.
For more information about Dsuvia, click here.